DLHL
NVS icon

Donald L. Hagan LLC’s Novartis NVS Stock Holding History

Donald L. Hagan LLC’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-946
Closed -$61K – 233
2016
Q1 		$61K Buy
+946
New +$64.4K 0.06% 129
2015
Q4 		– Sell
-946
Closed -$78K – 235
2015
Q3 		$78K Buy
+946
New +$84.2K 0.07% 107

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Donald L. Hagan LLC's NVS Position: Q2 2016 in Review

Donald L. Hagan LLC sold out of Novartis (NVS) in Q2 2016, closing a stake of 946 shares — an estimated $61K sold.

Donald L. Hagan LLC first reported a position in NVS in Q3 2015 and held it in 2 quarters. The position peaked at $78K in Q3 2015. 878 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

  • Donald L. Hagan LLC reported no remaining Novartis position as of Q2 2016 after selling out during the quarter.
  • Donald L. Hagan LLC sold 946 Novartis shares in Q2 2016, an estimated $61K.
  • Donald L. Hagan LLC first reported a position in Novartis in Q3 2015 and held it in 2 quarters.
  • Donald L. Hagan LLC's Novartis position peaked at $78K in Q3 2015.
  • 878 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Donald L. Hagan LLC's 13F filing for Q2 2016, filed 21 Jul 2016.